BEIJING – Chang Xin Memory Technologies, the Chinese chipmaker known as CXMT, raised $8.6 billion in an initial public offering on Shanghai’s STAR Market this week, attracting 212 times more investor demand than shares were available in what stands as China’s largest semiconductor listing and the most visible single act yet in Beijing’s effort to build a domestic competitor to Samsung, SK Hynix, and Micron Technology in the global market for DRAM chips.
The IPO priced CXMT at a market capitalization of roughly $85 billion, placing China’s most advanced DRAM producer in the same tier as SK Hynix and Micron by market value despite being significantly smaller in revenue and behind in process technology. Trading on the STAR Market, Shanghai Stock Exchange’s board for technology companies, is scheduled to begin July 27. The company is selling 57.9 billion yuan worth of shares, funding the next phase of capacity expansion at its Hefei manufacturing campus in Anhui province.
DRAM, Dynamic Random-Access Memory, is the type of semiconductor that enables computing to happen in real time. It is in every laptop, every smartphone, every data-center server, and every AI accelerator. The market is currently controlled by three companies: Samsung Electronics and SK Hynix in South Korea, which together hold roughly 75 percent of global DRAM production, and Micron Technology in the United States. CXMT is China’s attempt to build a fourth member of that oligopoly from the ground up, funded initially by state policy and now, with this offering, by public capital markets.
Founded in 2016 in Hefei, CXMT began production of LPDDR4 mobile DRAM in 2020 and has since expanded into DDR4 and DDR5 server-grade chips. Its current process technology is estimated to be roughly one to two generations behind Samsung and SK Hynix, a gap that is significant in a market where each new generation delivers meaningful improvements in performance per watt and cost per bit. The proceeds from the IPO are intended in part to close that gap by funding the next manufacturing node at the Hefei complex.
The 212x oversubscription is a striking number that reflects both genuine investor enthusiasm and the structural conditions of Chinese capital markets. Chinese institutional and retail investors face limited options for exposure to the country’s semiconductor buildout, and CXMT represents the most direct publicly traded vehicle for that exposure. Bloomberg and Reuters reported the oversubscription figure in the days following book-close.
The valuation deserves scrutiny. At $85 billion, CXMT is priced comparably to Micron Technology, which generates roughly three times more revenue and holds patents covering decades of DRAM development. SK Hynix, which produces more DRAM than CXMT by a factor of several multiples, trades at a similar market cap. The premium embedded in CXMT’s price reflects the growth optionality of a company expanding in a domestic market where import substitution is an explicit state priority, not purely the current financial reality of the company.
The US export control regime sits directly in CXMT’s expansion path. Since 2022, the Commerce Department has progressively restricted the sale of advanced semiconductor manufacturing equipment to Chinese chipmakers, targeting the lithography machines, deposition tools, and etch systems required to produce chips at the most advanced nodes. ASML, the Dutch company that makes the extreme ultraviolet lithography machines used at the leading edge, has been prohibited from selling them to China under Dutch export rules aligned with US policy. CXMT’s ability to advance its process technology is constrained by what equipment it can legally acquire, a ceiling that the IPO capital cannot simply purchase away.
That constraint is partly what makes the IPO’s timing politically significant. Raising $8.6 billion from public markets is a statement that China’s semiconductor industry has moved beyond the phase of purely state-directed capital and is now generating sufficient investor confidence to access the equity market at scale. Whether that confidence is well-founded at these valuations is a different question, but the structural shift is real. The fundraising also provides a form of political insurance: a company with hundreds of thousands of Chinese retail shareholders has a constituency that is difficult for any future government to simply wind down.
CXMT’s emergence as a public company comes against a broader backdrop in which China’s downstream memory chip users have been locking in supply at scale, signing multi-year contracts that exceed their annual revenues in a bid to secure access through a tightening cycle. Those downstream buyers, which include the server manufacturers, cloud providers, and consumer electronics companies that underpin China’s digital economy, are potential CXMT customers. The IPO connects the upstream chipmaker with the capital it needs to serve them at the volume required.
Samsung and SK Hynix have monitored CXMT’s development closely. The Korean companies occupy a dual position: they are CXMT’s primary competitors in the global market, but they have also historically supplied Chinese companies with the chips those companies need while domestic production scales. If CXMT succeeds in gaining share in the Chinese server market, the Koreans lose a major revenue source. If CXMT fails to close the technology gap, they continue supplying it. The outcome depends on a technology race constrained by export controls on one side and funded by IPO proceeds on the other.
Micron’s position is more direct. The US company generates significant revenue from Chinese customers, revenue that has been under pressure as Chinese buyers have been encouraged to diversify toward domestic suppliers where possible. Micron was barred from selling to certain Chinese state institutions in 2023 following a Chinese government security review, a ban that foreshadowed the broader shift. CXMT’s listing, and the capital it provides, is the investment community’s bet on how that shift resolves over the next several years, South China Morning Post noted in its coverage of the tightening global memory market that CXMT is entering.
What the $85 billion valuation cannot resolve is the technology question. An IPO funds equipment, people, and time. What it cannot buy directly is the institutional knowledge accumulated across decades of process development at Samsung’s fabs in Pyeongtaek and SK Hynix’s facilities in Icheon. That knowledge is embedded in thousands of process recipes, equipment configurations, and engineering decisions that are not transferable by capital alone. CXMT’s path to genuine parity requires closing a gap that is as much about organizational capability as it is about investment level. The July 27 listing gives it the money to try.
